Technology area: Chemistry & Materials
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days
Aker BioMarine Human Ingredients AS operates in the Chemistry & Materials technology area. The company currently has 1 pending office action in its patent portfolio. This action is being handled within 1 distinct art unit, which points to a specific focus on a particular technical niche. The presence of a single pending action suggests a targeted approach to its current intellectual property development within the Chemistry & Materials sector.
The prosecution for the company involves 1 distinct examiner. FAN, LYNN Y is the busiest examiner for the portfolio, currently managing 1 pending office action. This count is identical to the total number of pending actions for the entire company. For a practitioner, this means that the company's current interaction with the patent office is entirely concentrated under one examiner's review. This concentration allows for a focused prosecution strategy tailored to the specific requirements of this examiner and art unit.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Double-patenting only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| FAN, LYNN Y | 1 | 47.3% | +49.8% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18541250 | BIOEFFECTIVE KRILL OIL COMPOSITIONS | FAN, LYNN Y | 5d overdue |
| Art Unit | Apps |
|---|---|
| 1759 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18541250 | BIOEFFECTIVE KRILL OIL COMPOSITIONS | FAN, LYNN Y | 1759 | DP | Non-Final OA | 5d overdue | Pending | Dec 15, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialAker BioMarine Human Ingredients AS has 1 pending office actions as of October 2026, spread across 1 art units and 1 examiners.
Lynn Y Fan has the most, with 1 of Aker BioMarine Human Ingredients AS's pending office actions.
Mostly Chemistry & Materials (USPTO Tech Center 1700), based on where its pending office actions are examined.
